Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

313
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
313
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

213
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
213
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

321
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
321
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclosporine A protects against wasp venom-induced rhabdomyolysis in rats by inhibiting the CypD-mPTP pathway.

Toxicon : official journal of the International Society on Toxinology·2026
Same author

Guillain-Barré syndrome following <i>Escherichia coli</i> meningitis after cupping therapy: a case report.

Frontiers in immunology·2026
Same author

Postoperative foreign body retention following anal injury leading to a giant bladder stone: a case report.

BMC urology·2026
Same author

Extracorporeal membrane oxygenation for main airway rupture secondary to severe thoracic trauma: A case report.

Chinese journal of traumatology = Zhonghua chuang shang za zhi·2026
Same author

[Establishment of a toxic injury model induced by carbon monoxide in H9c2 cells].

Zhonghua wei zhong bing ji jiu yi xue·2026
Same author

Research progress on the relationship between mitochondrial dysfunction and inflammatory response in brain cells following traumatic brain injury: A review.

Experimental neurology·2026

Related Experiment Video

Updated: Jan 17, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

4.3K

TIM-3, a potential target for sepsis therapy.

Shaowen Huang1, Xiaofei Huang1, Xifeng Feng2

  • 1Department of Emergency, Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, Guizhou Province, China.

Chinese Journal of Traumatology = Zhonghua Chuang Shang Za Zhi
|September 14, 2025
PubMed
Summary
This summary is machine-generated.

T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) plays a dual role in sepsis immunity. Blocking TIM-3 may restore immune function and offer a new sepsis treatment strategy.

Keywords:
Costimulatory moleculeImmune dysregulationImmunotherapySepsisTIM-3

More Related Videos

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

20.0K
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.5K

Related Experiment Videos

Last Updated: Jan 17, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

4.3K
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

20.0K
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.5K

Area of Science:

  • Immunology
  • Sepsis Pathophysiology

Background:

  • Immune dysregulation significantly contributes to sepsis mortality.
  • T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) is a key regulator of immune responses in sepsis.
  • TIM-3's role is complex, with early upregulation potentially reducing inflammation and later sustained expression leading to immune exhaustion.

Purpose of the Study:

  • To explore the multifaceted role of TIM-3 in sepsis.
  • To investigate TIM-3 as a potential therapeutic target for sepsis.

Main Methods:

  • Review of current literature on TIM-3 function in sepsis.
  • Analysis of TIM-3's interactions with other immune checkpoints.
  • Examination of TIM-3's impact on immune cell function and apoptosis.

Main Results:

  • TIM-3 exhibits bidirectional effects, influencing inflammation and immune exhaustion differently across sepsis stages.
  • TIM-3 synergizes with other immune checkpoints like PD-1, worsening immunosuppression and increasing secondary infection risk.
  • Blocking TIM-3 signaling shows potential to restore immune cell function.

Conclusions:

  • TIM-3 is a promising biomarker and therapeutic target for sepsis.
  • Further research is needed to understand TIM-3's dynamic signaling pathways and optimize interventions.
  • Clinical trials are essential to validate combination immunotherapies targeting TIM-3 for sepsis treatment.